Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michail Sarafidis

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Brain Sciences|December 23, 2022
Development and Evaluation of Automated Tools for Auditory-Brainstem and Middle-Auditory Evoked Potentials Waves Detection and AnnotationOurania Manta, Michail Sarafidis, Nikolaos Vasileiou, et al.
International Journal of Cancer|December 27, 2024
Prognostic and predictive implications of sterile alpha motif and HD domain-containing protein 1 (SAMHD1) expression in breast cancerMaria Kouvaraki, Ioannis Zerdes, Emmanouil G Sifakis, et al.
Nature Communications|April 8, 2026
Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trialAlexios Matikas, Evangelos Tzoras, Michail Sarafidis, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Brain Sciences|December 23, 2022
Development and Evaluation of Automated Tools for Auditory-Brainstem and Middle-Auditory Evoked Potentials Waves Detection and AnnotationOurania Manta, Michail Sarafidis, Nikolaos Vasileiou, et al.
International Journal of Cancer|December 27, 2024
Prognostic and predictive implications of sterile alpha motif and HD domain-containing protein 1 (SAMHD1) expression in breast cancerMaria Kouvaraki, Ioannis Zerdes, Emmanouil G Sifakis, et al.
Nature Communications|April 8, 2026
Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trialAlexios Matikas, Evangelos Tzoras, Michail Sarafidis, et al.
Pageof 2